Search results
Feb 28, 2017 · For years, Behring had attempted to inactivate diphtheria toxin without diminishing its immunogenicity, e.g., using heat, but without success. Ultimately, he succeeded by forming complexes of a ntitoxin plus t oxin, in a vaccine called diphtheria AT.
Behring applied this same principle to diphtheria, creating a serum that could be used to combat the disease in humans.
May 10, 2010 · In the spring of 1913, Behring developed a vaccine against diphtheria. On May 15, 1914, a short article reported that the French newspaper Le Matin had declared the serum one of “the Seven ...
Dec 3, 2001 · The therapeutic serum developed by Behring prevented diphtheria for only a short period of time. In 1901, Behring, therefore, for the first time, used a diphtheria innoculation of bacteria with reduced virulence. With this active immunization he hoped to help the body also produce antitoxins.
Von Behring is believed to have cheated Paul Ehrlich out of recognition and financial reward in relation to collaborative research in diphtheria. The two men developed a diphtheria serum by repeatedly injecting the deadly toxin into a horse. The serum was used effectively during an epidemic in Germany.
Apr 10, 2017 · Emil von Behring (1854–1917) discovered passive immunization as an effective treatment for diphtheria and tetanus. Moreover, he brought this discovery from bench to bedside, and his serum...
Dec 1, 2022 · Behring investigated treatment of diphtheria using serum therapy, which is an alternative to vaccination that uses protective agents from other people’s blood to defend a patient against disease. Behring termed those protective agents antitoxins.
